Effects of moderate-to-vigorous intensity physical activity on overnight and next-day hypoglycemia in active adolescents with type 1 diabetes by Kristen M. Metcalf (7243046) et al.
Effects of Moderate-to-Vigorous
Intensity Physical Activity on
Overnight and Next-Day
Hypoglycemia in Active
Adolescents With Type 1 Diabetes
Diabetes Care 2014;37:1272–1278 | DOI: 10.2337/dc13-1973
OBJECTIVE
Physical activity (PA) provides many benefits to adolescents with type 1 diabetes;
however, these individuals tend to have lower fitness and PA levels than their
disease-free counterparts. The purpose of this study was to examine the acute
temporal associations between moderate-to-vigorous intensity PA (MVPA) and
hypoglycemia (continuous glucose monitor [CGM] reading £70 mg/dL).
RESEARCH DESIGN AND METHODS
Nineteen participants (53% females) 14–20 years old with type 1 diabetes
were recruited. Participant fitness was evaluated via indirect calorimetry
using a maximal exercise test; body composition wasmeasured using air displace-
ment plethysmography. An accelerometer was worn continuously (3–5 days) and
acceleration data used to estimate MVPA (minutes per day). Blood glucose values
were simultaneously tracked using CGM. Controlling for sex, percent body fat
(%BF), fitness, and concurrent MVPA, the likelihood of nighttime and next-day
hypoglycemia due to MVPA was examined using logistic regression.
RESULTS
Participants were of average fitness (females: 43.9 mL/kg/min; males: 49.8
mL/kg/min) and adiposity (females: 26.2%; males: 19.2%); 63.2% met the U.S.
federal guideline of accumulating 60 min/day of MVPA. Hypoglycemia was 31%
more likely in those who accumulated 30 min/day more MVPA in the previous
afternoon than those with less (95% CI 1.05–1.63; P = 0.017).
CONCLUSIONS
The results suggest that participating in afternoon MVPA increases the risk of
overnight and next-day hypoglycemia, independent of sex, %BF, fitness, and con-
current MVPA. While promoting PA as a healthy behavior, it is important to
educate adolescents with type 1 diabetes on prevention of hypoglycemia follow-
ing PA.
There are many benefits of physical activity (PA) in adolescents, including improved
blood lipid profiles, cardiovascular fitness, bone health, and psychological well-
being. PA is also inversely associated with levels of adiposity and stress (1). Not
only are these health outcomes immediately beneficial, but also health outcomes
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and physically active behavior track into
adulthood, further increasing the im-
portance of regular PA (1). The U.S. De-
partment of Health and Human Services’
2008 Physical Activity Guidelines for
Americans recommends a minimum of
60 min of moderate-to-vigorous inten-
sity PA (MVPA) daily for children and
adolescents (2). Despite the benefits of
PA, the latest data from the 2011 Cen-
ters for Disease Control and Prevention
Youth Risk Behavior Surveillance System
indicate that only 28.7% of high school
students are meeting the federal guide-
line of accumulating 60 min of MVPA
daily (3). Research shows that these pro-
portions are even lower for individuals
with chronic diseases, including type 1
diabetes (4,5). Specifically, adolescents
with type 1 diabetes spend 17 fewermin
in MVPA per day than healthy adoles-
cents and have 3–10 mL/kg/min lower
VO2max values (5,6).
While regular PA is an important as-
pect of disease management for adoles-
cents with type 1 diabetes, fear of
hypoglycemia may lead to low levels of
PA (7,8). This fear is valid because of the
counterregulatory systems that control
insulin levels not functioning properly,
increasing the risk of exercise-induced
hypoglycemia. Episodes of hypoglyce-
mia have been associated in children
and adolescents participating in pro-
longed moderate PA.60 min (9). Other
factors that affect the glycemic re-
sponse to exercise of an individual
with type 1 diabetes include exercise
duration, intensity, familiarity with
type of activity, metabolic control,
blood glucose levels, type and timing
of insulin injections and food intake, in-
sulin absorption, muscle mass required
for activity, conditioning, degreeof stress,
and timing of activity (10). Robertson
et al. (10) note that given consistent
timing of exercise, amount of insulin,
and pre-exercise meal, the response
to 60 min of PA can be reproducible,
indicating that it is safe for adolescents
with type 1 diabetes to be physically
active.
The relationship between PA and
glycemic control is complex. Some studies
have shown no benefit of PA on glycemic
control, as measured by HbA1c (11).
Others have shown that PA can reduce
insulin requirements by 6–15% (11).
This relationship, however, may be
moderated by certain factors. Luka´cs
et al. (5) have shown fitness to be in-
versely associated with HbA1c, while
other studies have failed to show an as-
sociation (12,13). Research on the rela-
tionship between adiposity and HbA1c
has shown mixed results. In one study,
BMI and adiposity were positively asso-
ciated with HbA1c (14); however, other
studies have failed to show a significant
association (5,9). Sex may or may not be
an importantmodifier in the relationship
between PA and glycemic control. Some
research shows a lack of association be-
tween sex and HbA1c (9), while others
cite males as having more favorable
HbA1c values, independent of PA, than
females (14).
Studies have looked at the complex
relationship between PA and glycemic
control in young patients with type 1
diabetes, butmost have used self-report
methods, such as questionnaires, to as-
sess daily PA participation (9,14–16).
While questionnaires are a cost- and
time-effective tool for assessing habit-
ual PA, accelerometers are a more accu-
rate measure of acute PA, as well as
total PA level and energy expenditure.
Additionally, accelerometers allow
viewing of daily activity patterns (17).
The aim of this study was to analyze
the relationship between MVPA and hy-
poglycemia through the assessment of
their acute, temporal associations. We
asked: 1) what are the acute, temporal
associations between MVPA and hypo-
glycemia in adolescents with type 1 di-
abetes and 2) are these associations
moderated by sex, fitness, or adiposity?
RESEARCH DESIGN AND METHODS
Consent Procedures
The Institutional Review Board at the
University of Iowa approved the study
protocol, assent, and consent form. A
parent or guardian provided written
consent for all participants ,18 years
old, and participants provided assent.
Participants .18 years old provided
their own consent. Participants were
also queried about their PA over the
past 7 days.
Eligibility Criteria and Assessment
To be eligible for the study, the partici-
pant had to: 1) be between 14 and 20
years of age and at least Tanner stage III
breast development for girls and at least
Tanner stage III genitalia development
for boys; 2) have a clinical diagnosis of
type 1 diabetes of $1 year duration; 3)
have a stable insulin regimen using an
insulin pump or multiple daily injections
for at least 12 months prior; 4) have an
HbA1c #10.0% in the past 3 months
measured with the DCA 2000 (Bayer Di-
agnostics, Tarrytown, NY); 5) have a BMI
between the 5th and 95th percentile for
age and sex; 6) have normal thyroid-
stimulating hormone in the past
12 months; and 7) be willing and able to
complete all study requirements. Partici-
pants were not eligible if they: 1) were
hospitalized in the past month; 2) used
systemic glucocorticoids in the past
month; 3) had amusculoskeletal problem
or physical or mental illness that may af-
fect exercise performance; or 4) had a
medical condition or were using a medi-
cation that, in the judgment of the inves-
tigator, could affect completion of the
exercise protocol.
Study Procedures
The study consisted of two visits to the
Clinical Research Unit of the Institute for
Clinical and Translational Science (ICTS)
at the University of Iowa separated by
3–5 days. During the first visit, the con-
tinuous glucose monitor (CGM) (SEVEN
PLUS; Dexcom, San Diego, CA) was cali-
brated and inserted subcutaneously, an-
thropometric measures and VO2max
testing were performed, and an acceler-
ometer (device model 1.1, GENEActiv;
Activinsights Ltd., Kimbolton, U.K.) was
placed on the left wrist. Participants
wore the CGM and accelerometer until
they returned for the second study visit.
Hypoglycemic Events
Interstitial glucose values were re-
corded in milligrams per deciliter using
CGM. Capillary glucose was checked
during the initial visit using the patient’s
home glucose meter at 2:00, 3:00, and
4:00 P.M., and these values were used to
calibrate the CGM. The CGM sensor was
placed subcutaneously during the initial
visit to the ICTS and removed upon com-
pletion of the second visit to the ICTS 3–
5 days later. The CGM collected glucose
readings every 5 min, 24 h/day, and was
calibrated with the patient’s home glu-
cose meter two times daily. Data from
the CGM were downloaded during the
second visit, and glucose values were
used to calculate the proportion of read-
ings qualified as a hypoglycemic event,
defined as any CGM reading#70mg/dL.
Alternative analyses were completed for
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hypoglycemic episodes, defined as suc-
cessive CGM readings #70 mg/dL, at
5-min intervals, with an episode ending
with at least two CGM readings .70
mg/dL.
Adiposity
Body fat and fat-free mass were mea-
sured using air displacement plethys-
mography via the BOD POD Gold
Standard Body Composition Tracking
System (model 2007A; COSMED USA,
Inc., Concord, CA). The BOD POD uses
bodymass and body volume to calculate
body density in grams per milliliter.
Body mass is measured using a platform
scale connected to the BOD POD, and
body volume is measured using air dis-
placement. Body density is then used to
calculate percent body fat (%BF) using
the Lohman density equation. The BOD
POD has excellent validity when com-
pared with dual energy X-ray absorpti-
ometry in young females, with an
intraclass correlation coefficient of
0.92 (18). In adolescent males, the
BOD POD has a correlation coefficient
of 0.90when comparedwith hydrostatic
weighing (19).
Cardiovascular Fitness
Cardiovascular fitness (VO2max) was
measured via maximal exercise testing
to volitional fatigue by open-circuit spi-
rometry using a metabolic cart (Parvo
Medics, Sandy, UT). Participants were
fitted with a heart rate chest strap (Polar
USA, Lake Success, NY) before com-
pleting a modified Balke treadmill pro-
tocol. Immediately before testing,
participants were seated for 5 min, after
which resting heart rate and blood pres-
sure were measured. Individuals then
practiced walking on the treadmill while
being given instructions on proper
treadmill walking technique. Partici-
pants self-selected a brisk but comfort-
able walking pace, and speeds ranged
from 3.0–4.0 mph at 0% grade, for an
initial 4-min warm-up. While keeping
the speed constant, the grade was
then increased to 5% for 4 min. Speed
was increased by 0.5 mph for 2 min,
after which the grade was increased by
2% each minute until exhaustion (20).
During the test, measures of gas ex-
change and heart rate were recorded.
Ratingof perceived exertionwas assessed
using Borg’s 15-point scale during each
stage. Participants were considered to
have reached their maximal effort
when two of the following criteria
were met: 1) heart rate $200; 2) respi-
ratory exchange ratio .1.0; or 3) #2
mL/kg/min change in VO2 in final 60 s
of test. VO2max in mL/kg/min was used
in analysis. Insulin levels were not ad-
justed for exercise, as the exercise ses-
sion was designed to mimic a typical
exercise session, and our participants
did not typically adjust for exercise.
If a participant experienced a bout of
hypoglycemia, he or she was treated
with 15 g of quick-acting carbohydrate
and then retested and retreated, if nec-
essary, after 15 min.
MVPA
Prior to fitness testing, a GENEActiv ac-
celerometer (Activinsights Ltd.) was
placed on the left wrist, to be worn be-
tween the two clinic visits for 3–5 days.
The GENEActiv has excellent criterion
validity in both adults (r = 0.86) and chil-
dren (r = 0.91) when worn at the left
wrist (21,22). Accelerometers were pro-
grammed to collect data, starting on the
initial visit day, at a frequency of 75 Hz.
Participants were instructed to wear the
monitor 24h/day, includingwhile sleeping
and during water activities. Accelerome-
ters were removed at the completion
of the participants’ second visit to the
ICTS, and data were downloaded. The
raw acceleration output was converted
to 60-s epochs using the GENEActiv
Post-Processing PC Software (version
2.2, GENEActiv; Activinsights Ltd.). Next,
the 60-s epoch data files were entered
into an open source Excel macro (v2; Ac-
tivinsights Ltd.) in order to classify activ-
ity as sedentary, light, moderate, or
vigorous intensity. MVPA (min/day)
was calculated for each participant-day.
Validated acceleration magnitude cut
points from Esliger et al. (21) were used
to classify activity intensity. KineSoft soft-
ware (version 3.3.75; KineSoft, Lough-
borough, U.K.) was used to produce a
series of standardized accelerometry
outcome variables following procedures
similar to those described by Esliger and
Tremblay (23) and Esliger et al. (24).
KineSoft was also used to produce heat
maps, which show the amount of time
spent in each activity intensity each day.
In addition to all-day MVPA (MVPATOT),
defined as 6:00 A.M. through bedtime
in minutes per day, hours of the day
were split in two for analysis: daytime
PA (MVPA06–15), defined as 6:00 A.M.
through 3:00 P.M.; and afternoon/
evening PA (MVPA15–BT), defined as
the post–school day activity hours of
3:00 P.M. through bedtime. Data were
collected between November 2011
and April 2012.
Statistical Analysis
Descriptive statistics, including mean, SD,
and range, were calculated for HbA1c,
MVPA (min/day), VO2 max (mL/kg/min),
adiposity (%BF), and number of hypo-
glycemic events. Sex-specific differen-
ces were evaluated using independent
sample t tests. Hypoglycemia was rep-
resented by the proportion of hypogly-
cemic events occurring overnight and
the next day following activity. Statisti-
cally significant associations between
MVPA, using 30-min increments, and
bouts of hypoglycemia were assessed
using logistic regression. Because we
were interested in acute effects, the lo-
gistic regression used individual days of
data collection rather than participants.
Generalized linear mixed-model analy-
sis was used to account for multiple out-
come measures per participant. Models
were constructed using previous-day
MVPA: 1) MVPATOT; 2) daytime MVPA
(MVPA06–15); and 3) afternoon/evening
MVPA (MVPA15–BT) as exposure varia-
bles. Bouts of hypoglycemia outcome
variables were: 1) overnight and next
day; 2) overnight (only); and 3) next
day (only). From the logistic regression,
odds ratios (ORs) and 95% CIs were cal-
culated. All models were adjusted for
sex, VO2max, %BF, and concurrent
MVPA (MVPA accumulated on the
same day as hypoglycemia risk was as-
sessed). Analysis was completed on all
days and weekdays only; however, the
results were not affected by removing
weekend days from analysis. Final anal-
ysis includes all days of theweek. P values
of ,0.05 were considered to be statisti-
cally significant. All statistical analyses
were performed using SAS (SAS version
9.3; SAS Institute, Cary, NC).
RESULTS
Twenty adolescents participated in the
study; however, analyses are based
on 19 participants (82 days of data), as
1 participant was lost to noncompliance
with study procedures. Participant char-
acteristics and covariates (age, height,
weight, %BF, VO2max, and MVPA),
HbA1c, and events of hypoglycemia are
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shown in Table 1. Average age of partic-
ipants was 16.6 6 1.6 years; 53% were
female. Males and females had mean
HbA1c values of 8.6 and 8.2%, respec-
tively. Participants were of average fit-
ness with a mean VO2max of 43.8
mL/kg/min for females (SD 6.8) and
49.8 mL/kg/min for males (SD 6.8)
(25). Participants also had average levels
of adiposity with a mean %BF in females
of 26.1% (SD 4.8), and 19.1% in males
(SD 9.3) (26). Sixty-three percent of par-
ticipantsmet theU.S. federal guideline for
adolescents of accumulating 60 min/day
of MVPA (2). Of the participants who
met the guideline, 75% (n = 9) reported
participating in organized sports during
the 7 days prior to the study. The mean
MVPA per day was 107.2 6 57.5 min in
males and 117.8 6 49.4 min in females.
There were no statistically significant dif-
ferences between male and female
participants for MVPA and events of hy-
poglycemia. A heat map of average time
spent in sedentary, light, moderate, and
vigorous physical activities throughout
the week by all participants is shown
in Fig. 1. The heat map represents all
19 participants for each day that they
wore the accelerometer and shows
the time spent in each intensity of PA
(minutes per hour) throughout each
day. The majority of each hour is spent
in sedentary and light-intensity activity,
with the highest amounts of MVPA
occurring in the late afternoon and early
evening hours. Due to small sample
size, our a priori analysis was between
MVPA and hypoglycemia, as informed
by previous research performed by the
Direcnet Study Group (9). Therefore,
we did not analyze sedentary and
light-intensity PA.
All 19 participants experienced at
least one bout of hypoglycemia over
the 82 participant-days analyzed. Four-
teen participants had one or more hypo-
glycemic events during the maximal
exercise test. The median number of hy-
poglycemic readings per day was 8.5
(range 0–87). Specifically, the average
number of hypoglycemic episodes over-
night was 0.7 per subject per night
(range 0–4); the median duration per
episode was 20 min (range 5–145). The
average number of hypoglycemic epi-
sodes the next day was 1.3 per subject
per day (range 0–7); the median dura-
tion per episode was 20 min (range 5–
135). The mean proportion of CGM
readings with a hypoglycemic event
was 4.45% of readings taken during
sleep and 5.45% of readings taken dur-
ing the day following activity.
Overnight and Next-Day
Hypoglycemia
Risk of hypoglycemia logistic regression
models described below were adjusted
for sex, VO2max, %BF, and concurrent
MVPA. Adjusted ORs for the full model
are presented in Table 2. Previous-day
MVPATOT (n = 50) was significantly asso-
ciated with overnight and next-day hy-
poglycemia (OR 1.26 [95% CI 1.08–1.46];
P = 0.003). For every 30-min increase in
previous-day MVPATOT, overnight and
next-day hypoglycemia risk increased
by 26%. When we segmented the pre-
vious day to more precisely examine
temporal responses, MVPA06–15 (n =
50) was associated with a higher risk of
overnight and next-day hypoglycemia
(OR 1.34 [95% CI 1.02–1.77]; P =
0.036). Additionally, MVPA15–BT (n =
67) was significant, with an OR of 1.36
(95%CI 1.13–1.63; P = 0.001). (MVPA15–BT
analyses have a higher sample size due
to the inclusion of initial visit day MVPA,
which was only available for afternoon
hours.)
Overnight Hypoglycemia
We also examined the risk of hypoglyce-
mia during overnight (as opposed to
overnight and next day). Previous-day
MVPATOT (n = 58) was significantly asso-
ciated with bouts of overnight hypogly-
cemia (OR 1.31 [95% CI 1.03–1.67]; P =
0.026). A nonsignificant association was
seen for the previous day for MVPA06–15
(n = 58) (OR 1.48 [95% CI 0.95–2.32]; P =
0.082); however, MVPA15–BT (n = 70)
was significant (OR 1.43 [95% CI 1.06–
1.93]; P = 0.021). Additionally, males
had a higher risk than females of ex-
periencing a bout of hypoglycemia
overnight (OR 3.14 [95% CI 1.16–8.47];
P = 0.026).
Next-Day Hypoglycemia
Finally, we examined the risk of hypogly-
cemia during the next day following ac-
tivity (as opposed to overnight and next
day). Previous-dayMVPATOT (n = 51)was
significantly associated with next-day
hypoglycemia (OR 1.28 [95% CI 1.07–
1.53]; P = 0.008). Increasing MVPA by
30 min/day significantly increased risk
of next-day hypoglycemia by 28%.
When the previous day’sMVPAwas seg-
mented, MVPA06–15 (n = 51) was not sig-
nificant (OR 1.11 [95% CI 0.83–1.49]; P =
0.454); however, MVPA15–BT (n = 68)
was (OR 1.31 [95% CI 1.05–1.63]; P =
0.017). Increasing MVPA15-BT by 30
min/day significantly increased risk of
next-day hypoglycemia by 31%. In addi-
tion, participants with a higher VO2max
had a higher risk of experiencing next-
day hypoglycemia than those with a
Table 1—Descriptive statistics for participant characteristics, MVPA, and
hypoglycemic events
Males (n = 9)* Females (n = 10)*
Age (years) 16.7 6 1.9 16.5 6 1.3
Height (m) 1.7 6 0.1 1.6 6 0.1
Weight (kg) 65.2 6 12.7 60.5 6 7.9
%BF† 19.2 6 9.4 26.2 6 4.8
Percent fat-free mass† 80.8 6 8.9 73.8 6 4.6
VO2max‡ 49.8 6 6.8 43.9 6 6.4
HbA1c [% (mmol/mol)] 8.6 (70) 6 0.9 (9.8) 8.2 (66) 6 0.9 (9.8)
MVPA all day (min) 107.2 6 57.5 117.8 6 49.4
MVPA daytime, 6:00 A.M.–2:59 P.M. (min) 45.4 6 36.7 56.5 6 26.5
MVPA afternoon/evening, 3:00 P.M.
to bedtime (min)§ 60.7 6 31.6 68.6 6 44.6
Overnight/next-day hypoglycemia (%)| 7.2 (4.8–10.8) 3.8 (2.2–6.5)
Overnight hypoglycemia (%) 5.4 (3.2–9.1) 3.4 (1.6–6.9)
Next-day hypoglycemia (%) 7.0 (4.6–10.5) 4.0 (2.3–6.8)
Data are presented asmean6 SD unless otherwise indicated. *Data were collected for 43 days for
males and 38 days for females. †%BF and percent fat-free mass determined by air-displacement
plethysmography. ‡VO2max measured using indirect calorimetry in a maximal exercise test.
§Bedtime varied by participant. Times ranged from 8:00 P.M. to 3:00 A.M., with an average
bedtime of 11:18 P.M. |Proportion of readings with hypoglycemic event (glucose #70 mg/dL).
Data presented as proportion (95% CI).
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lower VO2max. This relationship exists
for MVPA15–BT (OR 1.50 [95% CI 1.05–
2.16]; P = 0.030).
CONCLUSIONS
While PA providesmany benefits to ado-
lescents with type 1 diabetes, including
improvements in cardiovascular risk
profile, cardiovascular fitness, bone
health, and adiposity, there is a risk of
hypoglycemia after activity. In our
study, MVPA was assessed as total
minutes per day, daytime hours and
afternoon/evening hours. This strategy
was used to assess the effect of MVPA
accumulated during afterschool hours,
which is likely the most common time
to participate in MVPA, and is also the
time of most organized school athletics
practices. We found the greatest risk for
hypoglycemic events to be associated
with afternoon/evening MVPA. This
was the time that our participants accu-
mulated the greatest amount of MVPA;
in general, this is when adolescents ac-
cumulate the majority of their PA.
Participants in our study were of av-
erage fitness; our sample differs from
those in much of the previous literature,
which indicates that adolescents with
type 1 diabetes have lower levels of fit-
ness (5,6). The participants also accumu-
lated more daily MVPA than has been
reported in previous studies (4,13);
mean MVPA was 107.2 6 57.5 min/day
for males and 117.86 49.4 min/day for
females. Sixty-eight percent of the ado-
lescents participated in organized sports.
Given the study required a fitness and
body composition test, more active and
fit individuals may have volunteered. In
agreement with the previous literature
(5,14), participants had average adipos-
ity levels, and adiposity did not have an
effect on risk of hypoglycemia. Sex, how-
ever, was significant in the relationship
between MVPA and overnight hypogly-
cemia, with males having a greater risk.
Male participants had higher percent-
ages of fat-free mass, on average, than
the female participants, which may con-
tribute to this difference in risk, due
to increased skeletal muscle glucose
transport.
We report that in adolescents with
type 1 diabetes, a 30-min increase in
afternoon/evening MVPA increases the
risk of hypoglycemia by 43% overnight
and 31% on the following day. The asso-
ciations are independent of sex, fitness,
and adiposity, and the following-day re-
lationship is stronger when adjusted for
concurrent MVPA. The associations are
exponential; if an adolescent accumu-
lates the recommended 60 min/day of
MVPA, they have a 104 and 72% higher
risk for hypoglycemia overnight and
the following day, respectively, when
compared with no MVPA. An increased
risk of thismagnitudewarrants education
for not only the adolescent, but also for
coaches, parents, and school officials.
Organized sports often have practices
of 90–120 min, which would more than
double their risk of having a hypoglyce-
mic event. When adjusting for minutes
of MVPA, however, participants in orga-
nized sports did not differ in their hypo-
glycemia risk from those not in organized
sports. This indicates that participation
in organized sports does not increase hy-
poglycemia risk over independent activ-
ity of the same intensity and duration.
The results also indicated that higher fit-
ness is associated with an increased
risk for hypoglycemia of 50% (for every
5 mL/kg/min increase in VO2max). The
implication is that being fit or habitually
active does not protect against bouts of
hypoglycemia, but rather increases risk.
Participants with higher fitness had
lower %BF; higher amounts of lean
body mass aid in transporting glucose
into the muscles, leading to hypoglyce-
mia. Additionally, in our study, the more
fit adolescents had higher amounts of
vigorous intensity PA within their mi-
nutes of MVPA, suggesting that absolute
volume of PA (for example metabolic
equivalent of task minutes) may also in-
fluence hypoglycemia risk.
In agreement with previous research
completed by the DirecNet Study Group
(9), the current study found an in-
creased risk of overnight hypoglycemia
with more MVPA. Additionally, we
found an extended period of time in
which adolescents should be cognizant
of their blood glucose levels. This finding
indicates that there is an increased win-
dow of time of 32 h post activity in
which adolescents were at continued
risk of hypoglycemia.
Strengths of the current study include
the use of valid measures to obtain
study values, including the measure-
ment of VO2max using indirect calorim-
etry during a maximal exercise test, as
well as using air-displacement plethys-
mography to assess %BF. Another
strength was the use of CGM and 24-h
accelerometry to assess the temporal
associations between MVPA and hypo-
glycemia round the clock. Much of the
research in PA and adolescents with
type 1 diabetes has been completed
in a controlled laboratory setting. The
use of CGM and accelerometry allowed
for the analysis of the PA and hypogly-
cemia relationship in a free-living
Figure 1—Heat map of average physical activity patterns of all participants. aTimes based on
average activity of all participants (n = 19).
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setting, permitting the measurement of
participants’ normal daily activity.
Useof theGENEActiv is a strengthof this
study; it was used to decrease compliance
issues seen with other accelerometers.
The accelerometer was worn at the wrist
and is waterproof, ensuring participants
were able to comfortably wear the accel-
erometer 24 h/day, resulting in full-day
data collection. In our study, compliance
was measured as the proportion of days
with $600 min of wear time over the
number of anticipated collection days;
our compliance rate was 92%. Nineteen
of the 20 participants wore the monitor
at least 2 days for $600 min/day and
contributed to the analysis. Another
benefit of the GENEActiv is that data
are collected in units of raw acceleration
(21). The use of raw acceleration allows
for more transparent data analyses than
proprietary movement counts.
Limitations of the current study
include a small convenience sample. Ad-
ditionally, there were no dietary mea-
sures collected. Diet is an important
aspect of glycemic control, and could
affect hypoglycemic events. To partially
address this limitation, analyses were
completed adjusting for initial glucose
values during both sleep and waking
hours; however, they were not signifi-
cant. Use of CGM also presents limita-
tions, including loss of sensitivity during
bouts of hypoglycemia and numerical
errors (27). To address this limitation,
CGMs were calibrated twice daily with
patients’ home glucose meters. Future
analyses should continue to assess
patterns of hypoglycemia to better
determine a time of highest risk of
hypoglycemia.
We report that increasing afternoon/
evening MVPA results in an increased
risk of hypoglycemia overnight and dur-
ing the day following activity. Addition-
ally, higher fitness levels are associated
with an increased risk of hypoglycemia.
This indicates the importance of educat-
ing adolescents with type 1 diabetes, their
parents, and their coaches on prevention
of hypoglycemia following activity.
Acknowledgments. The authors thank all of
the study participants and the staff of the
Institute for Clinical and Translational Science
for the work completed.
Funding. This work was supported by a grant
from the Doris Duke Charitable Foundation, the
National Center for Advancing Translational
Sciences, and the National Institutes of Health
through grant 2-UL1-TR000442-06 for the In-
stitute for Clinical and Translational Science.
Duality of Interest. M.J.T. is a consultant for
Daiichi Sankyo. No other potential conflicts of
interest relevant to this article were reported.
Author Contributions. K.M.M. wrote the
manuscript and researched data. A.S., E.T.,
M.J.T., and D.W.E. researched data and re-
viewed and edited the manuscript. M.B.Z.
researched data and reviewed the manuscript.
K.F.J. designed the study, researched data, and
reviewed and edited the manuscript. K.M.M. is
the guarantor of this work and, as such, had full
access to all the data in the study and takes
responsibility for the integrity of the data and
the accuracy of the data analysis.
Table 2—ORs for temporal associations between daily MVPA and hypoglycemia
Variable OR (95% CI)*
Overnight and next day: MVPATOT
Next-day MVPA 0.89 (0.73–1.09)
Sex 1.70 (0.69–4.14)
VO2max 1.28 (0.85–1.93)
%BF 1.02 (0.94–1.10)
MVPA† 1.26 (1.08–1.46)‡
Overnight and next day: MVPA06–15
Next-day MVPA 0.89 (0.74–1.08)
Sex 1.58 (0.59–4.23)
VO2max 1.32 (0.84–2.07)
%BF 1.01 (0.93–1.10)
MVPA 1.34 (1.02–1.77)‡
Overnight and next day: MVPA15–BT
Next-day MVPA 0.90 (0.77–1.04)
Sex 1.93 (0.84–4.39)
VO2max 1.40 (0.95–2.07)
%BF 1.06 (0.98–1.13)
MVPA 1.36 (1.13–1.63)‡
Overnight: MVPATOT§
Sex 3.14 (1.16–8.47)‡
VO2max 0.79 (0.48–1.31)
%BF 1.00 (0.92–1.07)
MVPA 1.31 (1.03–1.67)‡
Overnight: MVPA06–15
Sex 2.83 (1.06–7.55)‡
VO2max 0.83 (0.51–1.36)
%BF 0.99 (0.92–1.06)
MVPA 1.48 (0.95–2.32)
Overnight: MVPA15–BT
Sex 2.53 (0.94–6.84)
VO2max 0.85 (0.52–1.38)
%BF 1.01 (0.94–1.09)
MVPA 1.43 (1.06–1.93)‡
Next day: MVPATOT
Next-day MVPA 0.84 (0.64–1.10)
Sex 1.50 (0.64–3.53)
VO2max 1.35 (0.94–1.94)
%BF 1.02 (0.95–1.10)
MVPA 1.28 (1.07–1.53)‡
Next day: MVPA06–15
Next-day MVPA 0.90 (0.71–1.13)
Sex 1.38 (0.50–3.85)
VO2max 1.43 (0.93–2.19)
%BF 1.02 (0.94–1.12)
MVPA 1.11 (0.83–1.49)
Next day: MVPA15–BT
Next-day MVPA 0.89 (0.74–1.08)
Sex 1.78 (0.80–3.98)
VO2max 1.50 (1.05–2.16)‡
%BF 1.06 (0.99–1.14)
MVPA 1.31 (1.05–1.63)‡
*ORs are calculated based on days of data collection and adjusted for sex, VO2max, %BF, and
concurrent MVPA. †OR is for an additional 30 min of MVPA per day. ‡Results significant at P#
0.05 level. §Overnight ORs are adjusted for sex, VO2max, and %BF.
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